CVS Health Co. (NYSE:CVS) Holdings Raised by SG Americas Securities LLC

SG Americas Securities LLC grew its stake in CVS Health Co. (NYSE:CVS - Free Report) by 47.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,801 shares of the pharmacy operator's stock after purchasing an additional 9,234 shares during the period. SG Americas Securities LLC's holdings in CVS Health were worth $1,293,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. State Street Corp increased its holdings in shares of CVS Health by 3.6% during the 3rd quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after buying an additional 1,989,066 shares during the last quarter. Geode Capital Management LLC increased its stake in CVS Health by 1.8% during the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock worth $1,651,997,000 after acquiring an additional 461,569 shares during the last quarter. Pzena Investment Management LLC raised its position in CVS Health by 1.5% in the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock valued at $825,948,000 after purchasing an additional 198,920 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of CVS Health by 2.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock valued at $767,681,000 after purchasing an additional 304,386 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC increased its position in shares of CVS Health by 34.8% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after purchasing an additional 3,071,613 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Piper Sandler lowered their price target on CVS Health from $72.00 to $64.00 and set an "overweight" rating for the company in a research report on Monday, November 25th. StockNews.com cut shares of CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. Truist Financial lowered their target price on shares of CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Finally, Evercore ISI upped their target price on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a report on Monday. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $68.12.

CVS Health Stock Up 2.2 %

Shares of CVS stock traded up $1.25 on Tuesday, hitting $57.45. The stock had a trading volume of 14,018,429 shares, compared to its average volume of 13,772,261. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The firm has a market capitalization of $72.29 billion, a price-to-earnings ratio of 14.58, a P/E/G ratio of 0.80 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock's 50 day moving average is $51.24 and its 200-day moving average is $56.19.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.21 earnings per share. As a group, research analysts expect that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.63%. CVS Health's dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.